FDA 483 - CSL Plasma Inc. - December 06, 2019

An FDA inspection of CSL Plasma in Decatur, IL, from December 3-6, 2019, identified one observation. The firm was cited for failing to properly prepare a phlebotomy site, which resulted in contamination during a donor's venipuncture. This indicates a lapse in ensuring sterile conditions for blood collection.